Prevention of surgical site infections: A systematic review of cost analyses in the use of prophylactic antibiotics

Frontiers in Pharmacology

Volumn 9, Issue JUL, 2018, Pages

  Purba, Abdul K R ^a,b   Setiawan, Didik ^c,d   Bathoorn, Erik ^a   Postma, Maarten J ^a,b,c,e   Dik, Jan Willem H ^a   Friedrich, Alex W ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b AIRLANGGA UNIVERSITY   (Indonesia)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d UNIVERSITAS MUHAMMADIYAH PURWOKERTO   (Indonesia)

^e UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Antibiotic prophylaxis; Bacterial pathogens; Costs and cost analysis; Health economic and outcome research; Surgical wound infection; Systematic review

Indexed keywords

AMIKACIN; AMPICILLIN PLUS CLOXACILLIN; ANTIBIOTIC AGENT; CEFALOTIN; CEFAZOLIN; CEFOTAXIME; CEFOTETAN; CEFPROZIL; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; ERTAPENEM; GENTAMICIN; METRONIDAZOLE; MOXIFLOXACIN; PENICILLIN G SODIUM; PSEUDOMONIC ACID; RIFAMPICIN; SULTAMICILLIN; TRICLOSAN; VANCOMYCIN;

ABDOMINAL SURGERY; ANTIBIOTIC PROPHYLAXIS; BLADDER SURGERY; BREAST SURGERY; CANCER SURGERY; COLON SURGERY; COLORECTAL SURGERY; COST BENEFIT ANALYSIS; DRUG COST; DRUG USE; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI INFECTION; GYNECOLOGIC SURGERY; HIP ARTHROPLASTY; HUMAN; INFECTION RATE; KLEBSIELLA PNEUMONIAE INFECTION; LAPAROSCOPIC CHOLECYSTECTOMY; NONHUMAN; OBSTETRIC OPERATION; PSEUDOMONAS INFECTION; RECTUM SURGERY; REVIEW; STAPHYLOCOCCUS INFECTION; STOMACH SURGERY; SURGICAL INFECTION; SYSTEMATIC REVIEW; THORAX SURGERY; TOTAL KNEE ARTHROPLASTY;

EID: 85050071173     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2018.00776     Document Type: Review

References (71)

1. Alekwe, L. O., Kuti, O., Orji, E. O., and Ogunniyi, S. O. (2008). Comparison of ceftriaxone versus triple drug regimen in the prevention of cesarean section infectious morbidities. J. Matern. Fetal. Neonatal Med. 21, 638-642. doi: 10.1080/14767050802220490
2. Allegranzi, B., Bagheri Nejad, S., Combescure, C., Graafmans, W., Attar, H., Donaldson, L., et al. (2011). Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet 377, 228-241. doi: 10.1016/S0140-6736(10)61458-4
3. Al-Mousa, H. H., Omar, A. A., Rosenthal, V. D., Salama, M. F., Aly, N. Y., El-Dossoky Noweir, M., et al. (2016). Device-associated infection rates, bacterial resistance, length of stay, and mortality in Kuwait: international Nosocomial infection consortium findings. Am. J. Infect. Control 44, 444-449. doi: 10.1016/j.ajic.2015.10.031
4. Anderson, D. J., Podgorny, K., Berrios-Torres, S. I., Bratzler, D. W., Dellinger, E. P., Greene, L., et al. (2014). Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect. Control Hosp. Epidemiol. 35(Suppl. 2), S66-S88. doi: 10.1086/676022
5. Ayliffe, G. A., Casewell, M. W., Cookson, B. D., Emmerson, A. M., Falkiner, F. R., French, G. L., et al. (1993). National prevalence survey of hospital acquired infections: definitions. a preliminary report of the Steering Group of the Second National Prevalence Survey. J. Hosp. Infect. 24, 69-76
6. Bell, C. M., Urbach, D. R., Ray, J. G., Bayoumi, A., Rosen, A. B., Greenberg, D., et al. (2006). Bias in published cost effectiveness studies: systematic review. BMJ 332, 699-703. doi: 10.1136/bmj.38737.607558.80
7. Berrios-Torres, S. I., Umscheid, C. A., Bratzler, D. W., Leas, B., Stone, E. C., Kelz, R. R., et al. (2017). Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg. 152, 784-791. doi: 10.1001/jamasurg.2017.0904
8. Brown, E. M., Pople, I. K., de Louvois, J., Hedges, A., Bayston, R., Eisenstein, S. M., et al. (2004). Spine update: prevention of postoperative infection in patients undergoing spinal surgery. Spine 29, 938-945
9. Caro, J. J., Briggs, A. H., Siebert, U., and Kuntz, K. M. (2012). Modeling good research practices-overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1. Med. Decis. Making 32, 667-677. doi: 10.1177/0272989X12454577
10. CDC (2010). Number and Standard Error of Discharges From Short-Stay Hospitals With and Without Procedures and Percentage With Procedures and Standard Eror by Selected Characteristics: United Stated, 2010. Available online at: https://www.cdc.gov/nchs/data/nhds/4procedures/2010pro_numberpercentage.pdf [Accessed March 4, 2017]
11. Ceballos, M., Orozco, L. E., Valderrama, C. O., Londono, D. I., and Lugo, L. H. (2017). Cost-effectiveness analysis of the use of a prophylactic antibiotic for patients undergoing lower limb amputation due to diabetes or vascular illness in colombia. Ann. Vasc. Surg. 40, 327-334. doi: 10.1016/j.avsg.2016.07.090
12. Chaudhuri, A., Bekdash, B. A., and Taylor, A. L. (2006). Single-dose metronidazole vs 5-day multi-drug antibiotic regimen in excision of pilonidal sinuses with primary closure: a prospective, randomized, double-blinded pilot study. Int. J. Colorectal Dis. 21, 688-692. doi: 10.1007/s00384-005-0064-7
13. Classen, D. C., Evans, R. S., Pestotnik, S. L., Horn, S. D., Menlove, R. L., and Burke, J. P. (1992). The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N. Engl. J. Med. 326, 281-286. doi: 10.1056/NEJM199201303260501
14. Courville, X. F., Tomek, I. M., Kirkland, K. B., Birhle, M., Kantor, S. R., and Finlayson, S. R. G. (2012). Cost-effectiveness of preoperative nasal mupirocin treatment in preventing surgical site infection in patients undergoing total hip and knee arthroplasty: a cost-effectiveness analysis. Infect. Control Hosp. Epidemiol. 33, 152-159. doi: 10.1086/663704
15. de Lissovoy, G., Fraeman, K., Hutchins, V., Murphy, D., Song, D., and Vaughn, B. B. (2009). Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am. J. Infect. Control 37, 387-397. doi: 10.1016/j.ajic.2008.12.010
16. Dhadwal, K., Al-Ruzzeh, S., Athanasiou, T., Choudhury, M., Tekkis, P., Vuddamalay, P., et al. (2007). Comparison of clinical and economic outcomes of two antibiotic prophylaxis regimens for sternal wound infection in high-risk patients following coronary artery bypass grafting surgery: a prospective randomised double-blind controlled trial. Heart 93, 1126-1133. doi: 10.1136/hrt.2006.103002
17. Dik, J. H., Poelman, R., Friedrich, A. W., Niesters, H. G. M., Rossen, J. W. A., and Sinha, B. (2017). Integrated stewardship model comprising antimicrobial, infection prevention, and diagnostic stewardship (AID Stewardship). J. Clin. Microbiol. 55, 3306-3307. doi: 10.1128/JCM.01283-17
18. Dik, J.-W. H., Friedrich, A. W., Nathwani, D., and Sinha, B. (2017). Combating the complex global challenge of antimicrobial resistance: what can antimicrobial stewardship contribute? Infect. Dis. Rep. 9:7158. doi: 10.4081/idr.2017.7158
19. Dik, J.-W. H., Vemer, P., Friedrich, A. W., Hendrix, R., Lo-Ten-Foe, J. R., Sinha, B., et al. (2015). Financial evaluations of antibiotic stewardship programs-a systematic review. Front. Microbiol. 6:317. doi: 10.3389/fmicb.2015.00317
20. Drummond, M. F., Sculpher, M. J., Claxton, K., Stoddart, G. L., and Torrance, G. W. (2015). Programmes, Methods for the Economic Evaluation of Health Care. Oxford: Oxford University Press
21. Eklund, A. M., Valtonen, M., and Werkkala, K. A. (2005). Prophylaxis of sternal wound infections with gentamicin-collagen implant: randomized controlled study in cardiac surgery. J. Hosp. Infect. 59, 108-112. doi: 10.1016/j.jhin.2004.10.005
22. Elliott, R. A., Weatherly, H. L. A., Hawkins, N. S., Cranny, G., Chambers, D., Myers, L., et al. (2010). An economic model for the prevention of MRSA infections after surgery: non-glycopeptide or glycopeptide antibiotic prophylaxis? Eur. J. Health Econ. 11, 57-66. doi: 10.1007/s10198-009-0175-0
23. El-Mahallawy, H. A., Hassan, S. S., Khalifa, H. I., El-Sayed Safa, M. M., and Khafagy, M. M. (2013). Comparing a combination of penicillin G and gentamicin to a combination of clindamycin and amikacin as prophylactic antibiotic regimens in prevention of clean contaminated wound infections in cancer surgery. J. Egypt. Natl. Canc. Inst. 25, 31-35. doi: 10.1016/j.jnci.2012.12.001
24. Emohare, O., Ledonio, C. G., Hill, B. W., Davis, R. A., Polly, D. W. J., and Kang, M. M. (2014). Cost savings analysis of intrawound vancomycin powder in posterior spinal surgery. Spine J. 14, 2710-2715. doi: 10.1016/j.spinee.2014.03.011
25. Evers, S., Goossens, M., de Vet, H., van Tulder, M., and Ament, A. (2005). Criteria list for assessment of methodological quality of economic evaluations: consensus on Health Economic Criteria. Int. J. Technol. Assess. Heal. Care 21, 240-245. doi: 10.1017.S0266462305050324
26. Evers, S. M. A. A., Hiligsmann, M., and Adarkwah, C. C. (2015). Risk of bias in trial-based economic evaluations: identification of sources and bias-reducing strategies. Psychol. Health 30, 52-71. doi: 10.1080/08870446.2014.953532
27. Friberg, O., Svedjeholm, R., Soderquist, B., Granfeldt, H., Vikerfors, T., and Kallman, J. (2005). Local gentamicin reduces sternal wound infections after cardiac surgery: a randomized controlled trial. Ann. Thorac. Surg. 79, 152-153. doi: 10.1016/j.athoracsur.2004.06.043
28. Graves, N., Wloch, C., Wilson, J., Barnett, A., Sutton, A., Cooper, N., et al. (2016). A cost-effectiveness modelling study of strategies to reduce risk of infection following primary hip replacement based on a systematic review. Health Technol. Assess. 20, 1-144. doi: 10.3310/hta20540
29. Gulluoglu, B. M., Guler, S. A., Ugurlu, M. U., and Culha, G. (2013). Efficacy of prophylactic antibiotic administration for breast cancer surgery in overweight or obese patients: a randomized controlled trial. Ann. Surg. 257, 37-43. doi: 10.1097/SLA.0b013e31826d832d
30. Horan, T. C., Gaynes, R. P., Martone, W. J., Jarvis, W. R., and Emori, T. G. (1992). CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect. Control Hosp. Epidemiol. 13, 606-608
31. Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., et al. (2013). Consolidated health economic evaluation reporting standards (CHEERS)-explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Heal. J. Int. Soc. Pharmacoecon. Outcomes Res. 16, 231-250. doi: 10.1016/j.jval.2013.02.002
32. Itani, K. M. F., Wilson, S. E., Awad, S. S., Jensen, E. H., Finn, T. S., and Abramson, M. A. (2006). Ertapenem versus cefotetan prophylaxis in elective colorectal surgery. N. Engl. J. Med. 355, 2640-2651. doi: 10.1056/NEJMoa054408
33. John-Baptiste, A., and Bell, C. (2010). Industry sponsored bias in cost effectiveness analyses. BMJ 341:c5350. doi: 10.1136/bmj.c5350
34. Jones, D. J., Bunn, F., and Bell-Syer, S. V. (2014). Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. Cochrane Database Syst. Rev. 9:CD005360. doi: 10.1002/14651858.CD005360.pub4
35. Jonsson, B. (2009). Ten arguments for a societal perspective in the economic evaluation of medical innovations. Eur. J. Health Econ. 10, 357-359. doi: 10.1007/s10198-009-0173-2
36. Joshi, V., Vaja, R., and Richens, D. (2016). Cost analysis of gentamicin-impregnated collagen sponges in preventing sternal wound infection post cardiac surgery. J. Wound Care 25, 22-25. doi: 10.12968/jowc.2016.25.1.22
37. Karanika, S., Grigoras, C., Flokas, M. E., Alevizakos, M., Kinamon, T., Kojic, E. M., et al. (2017). The attributable burden of Clostridium difficile infection to long-term care facilities stay: a clinical study. J. Am. Geriatr. Soc. 65, 1733-1740. doi: 10.1111/jgs.14863
38. Khodakaram, K., Stark, J., Hoglund, I., and Andersson, R. E. (2016). Minimal excision and primary suture is a cost-efficient definitive treatment for pilonidal disease with low morbidity: a population-based interventional and a cross-sectional cohort study. World J. Surg. 41, 1295-1302. doi: 10.1007/s00268-016-3828-z
39. Kosus, A., Kosus, N., Guler, A., and Capar, M. (2010). Rifamycin SV application to subcutaneous tissue for prevention of post cesarean surgical site infection. Eur. J. Gen. Med. 7, 269-276. doi: 10.29333/ejgm/82867
40. Kowalewski, M., Pawliszak, W., Zaborowska, K., Navarese, E. P., Szwed, K. A., Kowalkowska, M. E., et al. (2015). Gentamicin-collagen sponge reduces the risk of sternal wound infections after heart surgery: meta-analysis. J. Thorac. Cardiovasc. Surg. 149, 1631-1636. doi: 10.1016/j.jtcvs.2015.01.034
41. Lador, A., Nasir, H., Mansur, N., Sharoni, E., Biderman, P., Leibovici, L., et al. (2012). Antibiotic prophylaxis in cardiac surgery: systematic review and meta-analysis. J. Antimicrob. Chemother. 67, 541-550. doi: 10.1093/jac/dkr470
42. Leaper, D., Burman-Roy, S., Palanca, A., Cullen, K., Worster, D., Gautam-Aitken, E., et al. (2008). Prevention and treatment of surgical site infection: summary of NICE guidance. BMJ 337:a1924. doi: 10.1136/bmj.a1924
43. Leaper, D. J., and Edmiston, C. E. (2017). World Health Organization: global guidelines for the prevention of surgical site infection. J. Hosp. Infect. 95, 135-136. doi: 10.1016/j.jhin.2016.12.016
44. Lewis, A., Sen, R., Hill, T. C., James, H., Lin, J., Bhamra, H., et al. (2016). Antibiotic prophylaxis for subdural and subgaleal drains. J. Neurosurg. 126, 908-912. doi: 10.3171/2016.4.JNS16275
45. Mangram, A. J., Horan, T. C., Pearson, M. L., Silver, L. C., and Jarvis, W. R. (1999). Guideline for prevention of surgical site infection, 1999. centers for disease control and prevention (CDC) hospital infection control practices advisory committee. Am. J. Infect. Control 27, 97-132; quiz 133-4; discussion 96
46. Maseda, E., Rodriguez, A. H., Aguilar, G., Peman, J., Zaragoza, R., Ferrer, R., et al. (2016). EPICO 3.0. recommendations on invasive candidiasis in patients with complicated intra-abdominal infection and surgical patients with ICU extended stay. Rev. Iberoam. Micol. 33, 196-205. doi: 10.1016/j.riam.2016.02.003
47. Matsui, Y., Satoi, S., Kaibori, M., Toyokawa, H., Yanagimoto, H., Matsui, K., et al. (2014). Antibiotic prophylaxis in laparoscopic cholecystectomy: a randomized controlled trial. PLoS ONE 9:e106702. doi: 10.1371/journal.pone.0106702
48. Merollini, K. M. D., Crawford, R. W., Whitehouse, S. L., and Graves, N. (2013). Surgical site infection prevention following total hip arthroplasty in Australia: a cost-effectiveness analysis. Am. J. Infect. Control 41, 803-809. doi: 10.1016/j.ajic.2012.11.015
49. Messacar, K., Parker, S. K., Todd, J. K., and Dominguez, S. R. (2017). Implementation of rapid molecular infectious disease diagnostics: the role of diagnostic and antimicrobial stewardship. J. Clin. Microbiol. 55, 715-723. doi: 10.1128/JCM.02264-16
50. Moher, D., Liberati, A., Tetzlaff, J., and Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 6:e1000097. doi: 10.1371/journal.pmed.1000097
51. Mu, Y., Edwards, J. R., Horan, T. C., Berrios-Torres, S. I., and Fridkin, S. K. (2011). Improving risk-adjusted measures of surgical site infection for the national healthcare safety network. Infect. Control Hosp. Epidemiol. 32, 970-986. doi: 10.1086/662016
52. National Institutes of Health (2015). 2013 Annual Data Report. Natl. Inst. Diabetes Dig. Kidney Inst
53. Ogola, G. O., and Shafi, S. (2016). Cost of specific emergency general surgery diseases and factors associated with high-cost patients. J. Trauma Acute Care Surg. 80, 265-271. doi: 10.1097/TA.0000000000000911
54. Olsen, M. A., Chu-Ongsakul, S., Brandt, K. E., Dietz, J. R., Mayfield, J., and Fraser, V. J. (2008). Hospital-associated costs due to surgical site infection after breast surgery. Arch. Surg. 143, 53-60; discussion 61. doi: 10.1001/archsurg.2007.11
55. Ozdemir, S., Gulpinar, K., Ozis, S. E., Sahli, Z., Korkmaz, A., and Gecim, I. E. (2016). The effects of preoperative oral antibiotic use on the development of surgical site infection after elective colorectal resections: a retrospective cohort analysis in consecutively operated 90 patients. Int. J. Surg. 33, Pt A:102-108. doi: 10.1016/j.ijsu.2016.07.060
56. Palumbo, F. B., Barnes, R., Deverka, P., McGhan, W., Mullany, L., and Wertheimer, A. (2004). ISPOR Code of Ethics for Researchers background article-report of the ISPOR Task Force on Code of Ethics for Researchers. Value Heal. J. Int. Soc. Pharmacoecon. Outcomes Res. 7, 111-117
57. Patil, S., Kumar, T. N., and Mohiyuddin, A. (2011). Comparison of the use of single and combined antibiotics for head and neck onco-surgeries: a cost effective analysis. J. Clin. Diagnostic Res. 5, 769-771
58. Peel, A. L., and Taylor, E. W. (1991). Proposed definitions for the audit of postoperative infection: a discussion paper The report of a workshop convened by the following participants: surgical infection study group with the. Ann. R. Coll. Surg. Engl. 73, 385-388
59. Penel, N., Lefebvre, J.-L., Cazin, J. L., Clisant, S., Neu, J.-C., Dervaux, B., et al. (2008). Additional direct medical costs associated with nosocomial infections after head and neck cancer surgery: a hospital-perspective analysis. Int. J. Oral Maxillofac. Surg. 37, 135-139. doi: 10.1016/j.ijom.2007.08.002
60. Pereira, H. O., Rezende, E. M., and Couto, B. R. G. M. (2015). Length of preoperative hospital stay: a risk factor for reducing surgical infection in femoral fracture cases. Rev. Bras. Ortop. 50, 638-646. doi: 10.1016/j.rboe.2015.09.006
61. Roberts, R. R., Hota, B., Ahmad, I., Scott, R. D. II., Foster, S. D., Abbasi, F., et al. (2009). Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin. Infect. Dis. 49, 1175-1184. doi: 10.1086/605630
62. Salgado Yepez, E., Bovera, M. M., Rosenthal, V. D., Gonzalez Flores, H. A., Pazmino, L., Valencia, F., et al. (2017). Device-associated infection rates, mortality, length of stay and bacterial resistance in intensive care units in Ecuador: International Nosocomial Infection Control Consortium's findings. World J. Biol. Chem. 8, 95-101. doi: 10.4331/wjbc.v8.i1.95
63. Singh, A., Bartsch, S. M., Muder, R. R., and Lee, B. Y. (2014). An economic model: value of antimicrobial-coated sutures to society, hospitals, and third-party payers in preventing abdominal surgical site infections. Infect. Control Hosp. Epidemiol. 35, 1013-1020. doi: 10.1086/677163
64. Smaill, F. M., and Grivell, R. M. (2014). Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane database Syst. Rev. 28:CD007482. doi: 10.1002/14651858.CD007482.pub3
65. Thakore, R. V., Greenberg, S. E., Shi, H., Foxx, A. M., Francois, E. L., Prablek, M. A., et al. (2015). Surgical site infection in orthopedic trauma: a case-control study evaluating risk factors and cost. J. Clin. Orthop. Trauma 6, 220-226. doi: 10.1016/j.jcot.2015.04.004
66. Theologis, A. A., Demirkiran, G., Callahan, M., Pekmezci, M., Ames, C., and Deviren, V. (2014). Local intrawound vancomycin powder decreases the risk of surgical site infections in complex adult deformity reconstruction: a cost analysis. Spine 39, 1875-1880. doi: 10.1097/BRS.0000000000000533
67. The World Bank (2015). World Development Indicator. Available online at: http://databank.worldbank.org/data/reports.aspx?source=world-development-indicators (Accessed January 31, 2017)
68. Umscheid, C. A., Mitchell, M. D., Doshi, J. A., Agarwal, R., Williams, K., and Brennan, P. J. (2011). Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect. Control Hosp. Epidemiol. 32, 101-114. doi: 10.1086/657912
69. Wilson, S. E., Turpin, R. S., Kumar, R. N., Itani, K. M. F., Jensen, E. H., Pellissier, J. M., et al. (2008). Comparative costs of ertapenem and cefotetan as prophylaxis for elective colorectal surgery. Surg. Infect. 9, 349-356. doi: 10.1089/sur.2007.047
70. Xiong, L., Pan, Q., Jin, G., Xu, Y., and Hirche, C. (2014). Topical intrawound application of vancomycin powder in addition to intravenous administration of antibiotics: a meta-analysis on the deep infection after spinal surgeries. Orthop. Traumatol. Surg. Res. 100, 785-789. doi: 10.1016/j.otsr.2014.05.022
71. Zimlichman, E., Henderson, D., Tamir, O., Franz, C., Song, P., Yamin, C. K., et al. (2013). Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern. Med. 173, 2039-2046. doi: 10.1001/jamainternmed.2013.9763